Search Results 351-360 of 17316 for Teratogenic

  2. Olaparib and Atezolizumab Either Alone or in Combination in Treating Patients With Stage III-IV Triple Negative Breast Cancer - Mayo Clinic

    Pregnant women are excluded from this study because olaparib and atezolizumab are have the potential for teratogenic or abortifacient effects. Because there ...

  3. A Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability of Pegcetacoplan in Patients With TA-TMA After Hematopoietic Stem Cell Transplantation (HSCT) - Mayo Clinic

    A Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability of Pegcetacoplan in Patients With TA-TMA After Hematopoietic Stem Cell Transplantation ( ...

  4. ALPN-202 With PD-1 Inhibition in Advanced Malignancies - Mayo Clinic

    The purpose of this study is to evaluate ALPN-202 with PD-1 inhibition to treat adults with advanced solid tumors or lymphoma. Participation eligibility.

  5. Mayo Clinic Transplant Center - Doctors

    Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota.

  6. Doctors and departments - Mayo Clinic

    Atypical teratoid rhabdoid tumor (ATRT). Departments and specialties. Mayo Clinic has one of the largest and most experienced practices in the United States, ...

  7. A Long-term Follow-up Study Of Sotatercept For PAH Treatment (MK-7962-004/A011-12) - Mayo Clinic

    The primary objective of this open-label, LTFU study is to evaluate the long-term safety and tolerability of sotatercept when added to background PAH therapy in ...

  8. Mayo Clinic Transplant Center - Doctors

    Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota.

  9. A Study Evaluating Nelotanserin for Treatment of Visual Hallucinations in Subjects with Lewy Body Dementia - Mayo Clinic

    Inclusion Criteria. Adult aged 50 and older; Diagnosis of Lewy body dementia based on DSM-5 diagnostic criteria or diagnosis of Parkinson's disease dementia ...

  10. A Study to Evaluate Regorafenib with Cetuximab or Panitumumab to Treat Unresectable, Locally Advanced, or Metastatic Colorectal Cancer - Mayo Clinic

    Any of the following because this study involves an agent that has known genotoxic, mutagenic and teratogenic effects: Pregnant women. Nursing women. Men or ...